Exosomics Siena

Exosomics Siena Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Latest Deal Type
  • Later Stage VC
  • Investors
  • 6

Exosomics Siena General Information

Description

Developer of a biotechnology platform designed to launch a new generation of tests for cancer screening and liquid biopsy. The company's platform combines their patented approach for isolation of tumor derived exosomes from blood and urine with the state-of-art analytical methods, enabling the patients to get reliable and cost-effective treatments against cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Laboratory Services (Healthcare)
Biotechnology
Primary Office
  • Strada del Petriccio e Belriguardo 35
  • 53100 Siena
  • Italy
+39 0577 000000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Exosomics Siena Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 17-May-2017 Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2012 Completed Generating Revenue

Exosomics Siena Executive Team (2)

Name Title Board Seat Contact Info
Paolo Fabbrini President, Chairman and Chief Administrative Officer
Antonio Chiesi MD Founder, Chief Executive Officer and Board Member

Exosomics Siena Board Members (7)

To view Exosomics Siena‘s full board member team, request access »
Name Representing Role Since
Behzad Mahdavi Ph.D Lonza Group Chairman of the Board 000 0000
Luca Fantuzzi Self Board Member 000 0000
Mario Airoldi MD Self Board Member 000 0000
Mario Piccione Self Board Member 000 0000
Paolo Fabbrini Exosomics Siena President, Chairman and Chief Administrative Officer 000 0000

Exosomics Siena Investors (6)

To view Exosomics Siena‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Biofund Venture Capital Minority 000 0000 000000 0
Black Swan Trade Other Minority 000 0000 000000 0
FinBiotech Other Minority 000 0000 000000 0
HansaBioMed Life Sciences Other Minority 000 0000 000000 0
Lonza Group Corporation Minority 000 0000 000000 0

Ready to get started?

Request a free trial